The U.S. Court of Appeals for the Fifth Circuit opinion released Wednesday in Alliance for Hippocratic Medicine v. Food & Drug Administration is drawing strong reactions from state attorneys general.
The ruling issued by the U.S. Court of Appeals for the Fifth Circuit, held that mail-order access to mifepristone, a Federal Drug Administration-approved abortion pill, will no longer be available. Circuit Judge Jennifer Walker Elrod delivered the ruling Wednesday in Alliance for Hippocratic Medicine v. Food & Drug Administration, vacating a district court order in part and affirming in part.
